These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17503182)

  • 1. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial.
    Talley NJ; Kellow JE; Boyce P; Tennant C; Huskic S; Jones M
    Dig Dis Sci; 2008 Jan; 53(1):108-15. PubMed ID: 17503182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
    Tack J; Broekaert D; Fischler B; Van Oudenhove L; Gevers AM; Janssens J
    Gut; 2006 Aug; 55(8):1095-103. PubMed ID: 16401691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of imipramine in patients with irritable bowel syndrome.
    Abdul-Baki H; El Hajj II; Elzahabi L; Azar C; Aoun E; Skoury A; Chaar H; Sharara AI
    World J Gastroenterol; 2009 Aug; 15(29):3636-42. PubMed ID: 19653341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.
    Ladabaum U; Sharabidze A; Levin TR; Zhao WK; Chung E; Bacchetti P; Jin C; Grimes B; Pepin CJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):42-48.e1. PubMed ID: 19765674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL; Earl CQ; Walczak DD; Stoner KA; Wong LF; Kanter D; Houser VP
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.
    Rahimi R; Nikfar S; Rezaie A; Abdollahi M
    World J Gastroenterol; 2009 Apr; 15(13):1548-53. PubMed ID: 19340896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
    Bahar RJ; Collins BS; Steinmetz B; Ament ME
    J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation-predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bensoussan A; Kellow JE; Bourchier SJ; Fahey P; Shim L; Malcolm A; Boyce P
    Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1946-54.e1. PubMed ID: 26133902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acute serotonergic modulation on rectal motor function in diarrhea-predominant irritable bowel syndrome and healthy controls.
    van Nieuwenhoven MA; Kilkens TO
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1259-65. PubMed ID: 22890209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.
    Sohn W; Lee OY; Kwon JG; Park KS; Lim YJ; Kim TH; Jung SW; Kim JI
    Neurogastroenterol Motil; 2012 Sep; 24(9):860-e398. PubMed ID: 22679908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J;
    Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
    Kuiken SD; Tytgat GN; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2003 May; 1(3):219-28. PubMed ID: 15017494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants for irritable bowel syndrome-A systematic review.
    Kułak-Bejda A; Bejda G; Waszkiewicz N
    Pharmacol Rep; 2017 Dec; 69(6):1366-1379. PubMed ID: 29132094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram for pediatric functional abdominal pain: a randomized, placebo-controlled trial.
    Roohafza H; Pourmoghaddas Z; Saneian H; Gholamrezaei A
    Neurogastroenterol Motil; 2014 Nov; 26(11):1642-50. PubMed ID: 25244442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
    Krause R; Ameen V; Gordon SH; West M; Heath AT; Perschy T; Carter EG
    Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.